Search

everythinglearnresearchcommunity

for

Search:↓

Healthcare providers need better education and policies to serve transgender individuals effectively.

Tissue expansion is an effective treatment for certain types of hair loss, providing immediate coverage with hair-bearing skin.

Secondary aesthetic surgeries for gender reassignment are generally satisfying and advance overall aesthetic surgery techniques, but psychological support is important.

The document recommends the reviewed medical books for professionals in cosmetic surgery, dermatology, and genetics.

Google Trends data on facial cosmetic procedures matches actual surgery numbers, showing it can help plastic surgeons understand public interest.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

The safety and effectiveness of gender-affirming treatments for children are uncertain, with potential long-term risks like infertility.

Hormonal therapy changes skin and hair in transgender patients, who need better researched dermatologic care.

Follicular Unit Extraction (FUE) for hair transplants has limitations and may not be suitable for most patients.

A new hair transplant method showed promising results and a study found how deep a CO₂ laser can penetrate skin.

The guidelines recommend informed consent for gender-affirming treatments and stress the importance of personalized, culturally sensitive care for transgender individuals.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Fat-derived stem cells show promise for skin repair and reducing aging signs but need more research for consistent results.

Surgeons must understand the full care process for gender confirmation surgery to help transgender individuals effectively.

Most youth with gender dysphoria received hormones, had minor complications, and showed a decrease in suicide attempts after treatment.

Gynecologists should provide comprehensive care for transgender patients, including mental health evaluation, hormone therapy, and surgical options, while monitoring for side effects and ensuring patient safety.

The document concludes that cosmetic surgery is still mainly a practice for women and the gender gap in this field is expected to continue.

Fat tissue cells are a promising option for healing various diseases, but more research is needed to ensure they are safe and effective.

Fat-derived stem cells, platelet-rich plasma, and biomaterials show promise for healing chronic skin wounds and improving soft tissue with few side effects.

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.

Botox increased hair count in men with baldness and might work by improving scalp blood flow.

LGBT individuals have unique skin health needs, including higher STD risks and side effects from gender-affirming treatments, requiring dermatologists to offer knowledgeable and culturally competent care.

Hormone therapy and surgeries for transgender individuals affect their skin and hair, requiring specific dermatologic treatments and respectful care.

Using fat stem cells and blood cell-rich plasma together improves healing in diabetic wounds by affecting cell signaling.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

SVF-enhanced adipose transplantation shows potential as a hair loss treatment.

ADSC-CE treatment safely increases hair density and thickness in androgenetic alopecia patients.

Erbium glass laser treatment may help with skin remodeling, reduce inflammation, and improve skin cell maturation.

Using micro-needling, low-level laser therapy, and platelet-rich plasma together significantly improves hair growth in people with hair loss.

The document warns against US clinics selling untested stem cell treatments without FDA approval.